Atria Investments Inc cut its stake in U.S. Physical Therapy, Inc. (NYSE:USPH – Free Report) by 33.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,269 shares of the company’s stock after selling 3,129 shares during the period. Atria Investments Inc’s holdings in U.S. Physical Therapy were worth $531,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also made changes to their positions in the company. Canada Pension Plan Investment Board bought a new position in shares of U.S. Physical Therapy in the second quarter valued at approximately $28,000. Innealta Capital LLC bought a new stake in U.S. Physical Therapy during the second quarter worth approximately $30,000. Quest Partners LLC boosted its holdings in U.S. Physical Therapy by 2,808.3% during the second quarter. Quest Partners LLC now owns 349 shares of the company’s stock worth $32,000 after buying an additional 337 shares in the last quarter. Quarry LP boosted its holdings in U.S. Physical Therapy by 1,291.9% during the second quarter. Quarry LP now owns 515 shares of the company’s stock worth $48,000 after buying an additional 478 shares in the last quarter. Finally, Ridgewood Investments LLC bought a new stake in U.S. Physical Therapy during the second quarter worth approximately $51,000.
U.S. Physical Therapy Stock Up 0.8 %
Shares of NYSE:USPH opened at $90.63 on Wednesday. U.S. Physical Therapy, Inc. has a 52 week low of $76.18 and a 52 week high of $113.63. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. The company has a market cap of $1.37 billion, a PE ratio of 96.41, a price-to-earnings-growth ratio of 4.07 and a beta of 1.38. The firm has a 50 day simple moving average of $84.46 and a 200 day simple moving average of $90.82.
U.S. Physical Therapy Dividend Announcement
Insiders Place Their Bets
In related news, Director Bernard A. Harris, Jr. sold 2,000 shares of U.S. Physical Therapy stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $92.95, for a total value of $185,900.00. Following the completion of the sale, the director now owns 16,726 shares of the company’s stock, valued at approximately $1,554,681.70. The trade was a 10.68 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, COO Graham D. Reeve sold 1,724 shares of U.S. Physical Therapy stock in a transaction on Friday, November 8th. The shares were sold at an average price of $96.29, for a total transaction of $166,003.96. Following the completion of the sale, the chief operating officer now directly owns 7,106 shares of the company’s stock, valued at approximately $684,236.74. The trade was a 19.52 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 6,896 shares of company stock worth $656,940 in the last quarter. 1.70% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
USPH has been the subject of a number of research reports. Barrington Research restated an “outperform” rating and set a $108.00 target price on shares of U.S. Physical Therapy in a report on Thursday, November 7th. StockNews.com upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, August 21st. Finally, Bank of America restated a “neutral” rating and set a $90.00 target price (down from $114.00) on shares of U.S. Physical Therapy in a report on Monday, October 7th.
View Our Latest Stock Analysis on USPH
About U.S. Physical Therapy
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Read More
- Five stocks we like better than U.S. Physical Therapy
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- How to Effectively Use the MarketBeat Ratings Screener
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- 3 Hot Stock Trends to Ride Into 2025
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.